期刊文献+
共找到5篇文章
< 1 >
每页显示 20 50 100
渥丹百合农艺性状及活性成分对钾元素的响应 被引量:1
1
作者 王云霞 张萍 +3 位作者 葛蓓蕾 雅蓉 杨英 靳磊 《草业学报》 CSCD 北大核心 2021年第6期205-213,共9页
为探明钾素与渥丹百合生长发育及鳞茎活性成分积累的关系,采用Hoagland营养液浇灌技术,研究不同钾水平(K_(0)、K_(1)、K_(2)、K_(3)、K_(4))对渥丹百合株高、茎粗、叶片数、叶绿素含量的影响,采用分光光度法、火焰光度法测定并分析了鳞... 为探明钾素与渥丹百合生长发育及鳞茎活性成分积累的关系,采用Hoagland营养液浇灌技术,研究不同钾水平(K_(0)、K_(1)、K_(2)、K_(3)、K_(4))对渥丹百合株高、茎粗、叶片数、叶绿素含量的影响,采用分光光度法、火焰光度法测定并分析了鳞茎中活性物质(多糖、总酚、总黄酮、皂苷)及钾含量的积累。结果表明:1)渥丹百合农艺性状对钾水平的响应差异显著(P<0.05),其中K4(895.2 mg·L^(-1))水平下株高和叶片叶绿素含量达最大值,K3(671.4 mg·L^(-1))水平茎粗与鳞茎周径达最大值;2)与不施钾(K0)相比,各处理均对鳞茎中活性成分影响差异显著(P<0.05),尤其K4水平提高了多糖、总酚、总黄酮和皂苷含量,分别是K0的2.87、4.33、5.79、1.57倍;3)各处理下鳞茎中钾含量在0.29%~1.31%,其中K2水平效果显著,较K0提高了22.90%;4)相关性分析表明,4种活性物质均与钾浓度呈正相关,尤其半枯期鳞茎周径与钾浓度存在显著正相关,相关系数为0.83。以上结果可为百合优质栽培提供理论依据。 展开更多
关键词 渥丹百合 钾元素 农艺性状 活性成分
下载PDF
Pancreatic T/histiocyte-rich large B-cell lymphoma: A case report and review of literature 被引量:6
2
作者 Shu-Mei Zheng De-Jiang Zhou +7 位作者 Yi-Hua Chen Rui Jiang yun-xia wang Yong Zhang Hong-Li Xue Hai-Qiong wang Dong Mou Wei-Zheng Zeng 《World Journal of Gastroenterology》 SCIE CAS 2017年第24期4467-4472,共6页
Primary pancreatic lymphoma(PPL)is an extremely rare form of extranodal malignant lymphoma.The most common histological subtype of PPL is diffuse large B cell lymphoma(DLBCL).In rare cases,PPL can also present as foll... Primary pancreatic lymphoma(PPL)is an extremely rare form of extranodal malignant lymphoma.The most common histological subtype of PPL is diffuse large B cell lymphoma(DLBCL).In rare cases,PPL can also present as follicular lymphoma,small lymphocytic lymphoma,and T cell lymphoma either of non-Hodgkin’s lymphoma or of Hodgkin’s lymphoma.T-cell/histiocyterich large B-cell lymphoma(T/HRBCL)is an uncommon morphologic variant of DLBCL with aggressive clinical course,it is predominantly a nodal disease,but extranodal sites such as bone marrow,liver,and spleen can be involved.Pancreatic involvement of T/HRBCL was not presented before.Herein,we report a 48-year-old male who was hospitalized with complaints of jaundice,dark brown urine,pale stools,and nausea.The radiological evaluation revealed a pancreatic head mass and,following operative biopsy,the tumor was diagnosed as T/HRBCL.The patient achieved remission after six cycles of CHOP chemotherapy.Therefore,T/HRBCL can be treated similarly to the stage-matched DLBCL and both of them get equivalent outcomes after chemotherapy. 展开更多
关键词 Non-Hodgkins 淋巴瘤 T-cell/histiocyte-rich B 房间淋巴瘤 IMMUNOHISTOCHEMISTRY 主要胰腺的淋巴瘤 诊断
下载PDF
Expert consensus of the Chinese Association for the Study of Pain on ion channel drugs for neuropathic pain 被引量:5
3
作者 Hong Xiao Ke Ma +12 位作者 Dong Huang Xian-Guo Liu Tang-Hua Liu Qing Liu Guang-Zhao Liu Tao Song Wei Tao Da-Sheng Wu yun-xia wang Xiao-Qiu Yang Xiao-Mei Zhang Hui Liu Yan-Qing Liu 《World Journal of Clinical Cases》 SCIE 2021年第9期2100-2109,共10页
Neuropathic pain(NPP)is a kind of pain caused by disease or damage impacting the somatosensory system.Ion channel drugs are the main treatment for NPP;however,their irregular usage leads to unsatisfactory pain relief.... Neuropathic pain(NPP)is a kind of pain caused by disease or damage impacting the somatosensory system.Ion channel drugs are the main treatment for NPP;however,their irregular usage leads to unsatisfactory pain relief.To regulate the treatment of NPP with ion channel drugs in clinical practice,the Chinese Association for the Study of Pain organized first-line pain management experts from China to write an expert consensus as the reference for the use of ion channels drugs.Here,we reviewed the mechanism and characteristics of sodium and calcium channel drugs,and developed recommendations for the therapeutic principles and clinical practice for carbamazepine,oxcarbazepine,lidocaine,bulleyaconitine A,pregabalin,and gabapentin.We hope this guideline provides guidance to clinicians and patients on the use of ion channel drugs for the management of NPP. 展开更多
关键词 Ion channel drug Neuropathic pain Expert consensus Guideline GABAPENTIN CARBAMAZEPINE OXCARBAZEPINE Lidocaine Bulleyaconitine A PREGABALIN
下载PDF
Expert consensus of the Chinese Association for the Study of Pain on pain treatment with the transdermal patch 被引量:1
4
作者 Ke Ma Wei Jiang +14 位作者 yun-xia wang Lin wang Yan Lv Jin-Feng Liu Rong-Guo Liu Hui Liu Li-Zu Xiao Dong-Ping Du Li-Juan Lu Xiao-Qiu Yang Ling-Jie Xia Dong Huang Zhi-Jian Fu Bao-Gan Peng Yan-Qing Liu 《World Journal of Clinical Cases》 SCIE 2021年第9期2110-2122,共13页
Chronic pain lasting more than 3 mo,or even several years can lead to disability.Treating chronic pain safely and effectively is a critical challenge faced by clinicians.Because administration of analgesics through or... Chronic pain lasting more than 3 mo,or even several years can lead to disability.Treating chronic pain safely and effectively is a critical challenge faced by clinicians.Because administration of analgesics through oral,intravenous or intramuscular routes is not satisfactory,research toward percutaneous delivery has gained interest.The transdermal patch is one such percutaneous delivery system that can deliver drugs through the skin and capillaries at a certain rate to achieve a systemic or local therapeutic effect in the affected area.It has many advantages including ease of administration and hepatic first pass metabolism avoidance as well as controlling drug delivery,which reduces the dose frequency and side effects.If not required,then the patch can be removed from the skin immediately.The scopolamine patch was the first transdermal patch to be approved for the treatment of motion sickness by the Food and Drug Administration in 1979.From then on,the transdermal patch has been widely used to treat many diseases.To date,no guidelines or consensus are available on the use of analgesic drugs through transdermal delivery.The pain branch of the Chinese Medical Association,after meeting and discussing with experts and based on clinical evidence,developed a consensus for promoting and regulating standard use of transdermal patches containing analgesic drugs. 展开更多
关键词 Transdermal drug delivery systems PAIN Transdermal patches TOPICAL Nonsteroidal anti-inflammatory drugs ANALGESICS
下载PDF
Regulation of oxidative stress inside living cells through polythiophene derivatives
5
作者 Rong Hu Sheng-Liang Li +4 位作者 Hao-Tian Bai yun-xia wang Li-Bing Liu Feng-Ting Lv Shu wang 《Chinese Chemical Letters》 SCIE CAS CSCD 2016年第4期545-549,共5页
Oxidative stress stimulated by angiotensin II(Ang II) plays an important role in the progression of inflammation and cardiovascular disease. In this work, polythiophene modified with dihydropyridine groups(PTDHP) real... Oxidative stress stimulated by angiotensin II(Ang II) plays an important role in the progression of inflammation and cardiovascular disease. In this work, polythiophene modified with dihydropyridine groups(PTDHP) realized the control of oxidative stress induced by Angiotensin II stimulation in living cells, by inhibiting the activity of NADPH oxidase via DHP groups. Upon light irradiation, the PTDHP could sensitize surrounding oxygen molecules to generate reactive oxygen species(ROS). The generated ROS oxidized the pendant DHP of polythiophene into pyridine group, which inactivated the control ability of DHP to oxidative stress in living cells. Thus, PTDHP can not only control the intracellular oxidative stress effectively and suppress ROS to some degree in dark, but also regulate its anti-oxidative effect under light irradiation. 展开更多
关键词 氧化应激 聚噻吩 细胞内 生物调节 血管紧张素II NADPH氧化酶 心血管疾病 抗氧化作用
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部